The Food and Drug Administration approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. The company's ...

The Food and Drug Administration on Monday approved Pfizer’s RSV vaccine to protect infants by vaccinating pregnant parents, becoming the first maternal shot to reach market and offering hope of ...

A Pfizer Inc. PFE, -0.48% vaccine designed to protect babies from respiratory syncytial virus, or RSV, got a green light Monday from the U.S. Food and Drug Administration — a key milestone for ...

The FDA has signed off on the new Novavax shot, giving people another vaccine option this season. Here's a breakdown of ...

(The Hill) – The Food and Drug Administration (FDA) on Monday approved the first vaccine meant to prevent infections in infants, with the new drug designed to be administered to pregnant mothers ...

The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer's ...

An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory ...

This is a carousel. Use Next and Previous buttons to navigate WASHINGTON (AP) — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with ...

For the first time ever, people older than 60 and pregnant women can get a vaccine to protect against RSV, a contagious and deadly virus.

Pfizer Inc. (PFE) receives CDC endorsement for its maternal RSV vaccine, Abrysvo, with a potential revenue of $2 billion, marking a pivotal advancement in healthcare and highlighting Pfizers ...

WASHINGTON (AP) — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is ...

An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory ...